5 – 6 July 2024, virtual. Dr Razis, Dr Labropoulos and Dr Kalapanida will
participate virtually in the conference "Best of ASCO 2024, Event in Greece"
in the session: "CNS Tumors". Dr Kalapanida will present the following
Abstracts:
 Abstract 2000 | N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly
matched targeted therapies plus radiotherapy in patients with newly
diagnosed glioblastoma without MGMT promoter hypermethylation.
 Abstract 2013 | A phase II trial of olaparib and durvalumab in patients
with
recurrent IDH-mutated gliomas.
 Abstract 2002 | Niraparib efficacy in patients with newly diagnosed
glioblastoma: Clinical readout of a phase 0/2 “trigger” trial.

Dr Razis and Dr Labropoulos will preside at the lecture while Dr Razis will
also be a discussant.